[PDF][PDF] The intriguing carbapenemases of Pseudomonas aeruginosa: Current status, genetic profile, and global epidemiology

Yale J. Biol. Med, 2022 - pdfs.semanticscholar.org
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology

DH Halat, CA Moubareck - The Yale Journal of Biology and …, 2022 - search.proquest.com
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology

DH Halata, CA Moubareckb - YALE JOURNAL OF BIOLOGY AND …, 2022 - europepmc.org
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology

DH Halat, CA Moubareck - Yale Journal of Biology and …, 2022 - nchr.elsevierpure.com
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology

DH Halat, CA Moubareck - The Yale journal of biology …, 2022 - pubmed.ncbi.nlm.nih.gov
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology.

The Yale Journal of Biology and Medicine, 2022 - europepmc.org
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …